XML 67 R51.htm IDEA: XBRL DOCUMENT v3.22.4
Stock-Based Compensation (Details) - Schedule of stock option plan activity - USD ($)
12 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Schedule Of Stock Option Plan Activity Abstract    
Number of Options, Outstanding at beginning 1,122,560 492,842
Weighted Average Exercise Price, Outstanding at beginning $ 5.89 $ 6.13
Weighted- Average Remaining Contractual Term (years), Outstanding at beginning 8 years 8 years 9 months 18 days
Aggregate Intrinsic Value, Outstanding at beginning [1]   $ 96,088
Number of Options, Granted 152,690 703,117
Weighted Average Exercise Price, Granted $ 1.5 $ 5.83
Weighted- Average Remaining Contractual Term (years), Granted
Aggregate Intrinsic Value, Granted [1]
Number of Options, Exercised (1,538)
Weighted Average Exercise Price, Exercised $ 6.6
Weighted- Average Remaining Contractual Term (years), Exercised
Aggregate Intrinsic Value, Exercised [1]
Number of Options, Forfeited/Cancelled (35,335) (71,861)
Weighted Average Exercise Price, Forfeited/Cancelled $ 4.14 $ 6.85
Weighted- Average Remaining Contractual Term (years), Forfeited/Cancelled
Aggregate Intrinsic Value, Forfeited/Cancelled [1]
Number of Options, Outstanding at ending 1,239,915 1,122,560
Weighted Average Exercise Price, Outstanding at ending $ 5.4 $ 5.89
Weighted- Average Remaining Contractual Term (years), Outstanding at ending 8 years 8 years 9 months 18 days
Aggregate Intrinsic Value, Outstanding at ending [1] $ 89,295 $ 127,339
Number of Options, Vested and expected 1,239,915  
Weighted Average Exercise Price, Vested and expected $ 5.4  
Weighted- Average Remaining Contractual Term (years),Vested and expected 8 years  
Aggregate Intrinsic Value, Vested and expected [1] $ 89,295  
Number of Options, Vested and exercisable 783,494  
Weighted Average Exercise Price, Vested and exercisable $ 5.76  
Weighted- Average Remaining Contractual Term (years), Vested and exercisable 7 years 8 months 12 days  
Aggregate Intrinsic Value, Vested and exercisable [1] $ 56,542  
[1] The aggregate intrinsic value is calculated as the difference between the exercise price of the underlying options and the fair value of our common stock as of September 30, 2022 and 2021 of $1.69 and $3.95 per share, respectively. As of September 30, 2022 and 2021, 1,125,710 and 1,055,376 outstanding options, respectively, had no intrinsic value.